EB Clinical Research Consortium (EBCRC) Grants
Supports Clinical research grants for EB therapy development through the EBCRC collaborative network.
EB Clinical Research Consortium Grants sit under the same EB Research Partnership and DEBRA of America umbrella as the project-grant route, but this program is the more clinical lane. It is aimed at clinical research inside the EB Clinical Research Consortium network, so it is the route to watch when the work has already moved past early exploratory study and into patient-facing development. Public information is limited. The next application cycle is Q3 2026, the website does not publish award sizes, and the portal holds the detailed eligibility and application instructions. The public page also points applicants to Humane Care documentation and Human Subjects approvals, which signals that the program expects serious clinical governance rather than light-touch concept work. Nonprofits, universities, and research organizations are listed as eligible, while for-profit applicants are not. The fit is narrow but clear: teams that already belong in a clinical EB research setting and can work through portal-only instructions will be the best match. Because the public page leaves the financial terms and the full eligibility grid unpublished, applicants should treat direct portal review as part of the process and align tightly with the consortium's clinical priorities. For groups that need a less clinical or more pre-clinical route, the separate EB Research Project Grants program is the broader entry point.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.